Omega-3 polyunsaturated fatty acids ameliorate ethanol-induced adipose hyperlipolysis: A mechanism for hepatoprotective effect against alcoholic liver disease

Altamirano, 2011, Alcoholic liver disease: pathogenesis and new targets for therapy, Nat. Rev. Gastroenterol. Hepatol., 8, 491, 10.1038/nrgastro.2011.134 Wang, 2016, Dietary alpha-linolenic acid-rich flaxseed oil prevents against alcoholic hepatic steatosis via ameliorating lipid homeostasis at adipose tissue-liver axis in mice, Sci. Rep., 6, 26826, 10.1038/srep26826 You, 2004, Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver, Am. J. Physiol. Gastrointest. Liver Physiol., 287, G1, 10.1152/ajpgi.00056.2004 Lakshman, 2004, Some novel insights into the pathogenesis of alcoholic steatosis, Alcohol, 34, 45, 10.1016/j.alcohol.2004.08.004 Ma, 2016, Potential link between excess added sugar intake and ectopic fat: a systematic review of randomized controlled trials, Nutr. Rev., 74, 18, 10.1093/nutrit/nuv047 Suganami, 2012, Adipose tissue inflammation and ectopic lipid accumulation, Endocr. J., 59, 849, 10.1507/endocrj.EJ12-0271 Zhong, 2012, Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis, Am. J. Pathol., 180, 998, 10.1016/j.ajpath.2011.11.017 Zechner, 2012, FAT SIGNALS–lipases and lipolysis in lipid metabolism and signaling, Cell Metab., 15, 279, 10.1016/j.cmet.2011.12.018 Egan, 1992, Mechanism of hormone-stimulated lipolysis in adipocytes: translocation of hormone-sensitive lipase to the lipid storage droplet, Proc. Natl. Acad. Sci. U. S. A., 89, 8537, 10.1073/pnas.89.18.8537 Wang, 2016, Curcumin inhibits lipolysis via suppression of ER stress in adipose tissue and prevents hepatic insulin resistance, J. Lipid Res., 57, 1243, 10.1194/jlr.M067397 Green, 2004, Stimulation of lipolysis by tumor necrosis factor-alpha in 3T3-L1 adipocytes is glucose dependent: implications for long-term regulation of lipolysis, Diabetes, 53, 74, 10.2337/diabetes.53.1.74 Sebastian, 2011, Identification of a cytochrome P4502E1/Bid/C1q-dependent axis mediating inflammation in adipose tissue after chronic ethanol feeding to mice, J. Biol. Chem., 286, 35989, 10.1074/jbc.M111.254201 Tang, 2012, Ethanol-induced oxidative stress via the CYP2E1 pathway disrupts adiponectin secretion from adipocytes, Alcohol. Clin. Exp. Res., 36, 214, 10.1111/j.1530-0277.2011.01607.x Wan, 2010, Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-deficient mice by inhibiting systemic and vascular inflammation, Arterioscler. Thromb. Vasc. Biol., 30, 2487, 10.1161/ATVBAHA.110.210054 Bellenger, 2011, High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition, Diabetes, 60, 1090, 10.2337/db10-0901 Lebbadi, 2011, Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease, J. Alzheimers Dis., 27, 853, 10.3233/JAD-2011-111010 Huang, 2013, Suppression of acute ethanol-induced hepatic steatosis by docosahexaenoic acid is associated with downregulation of stearoyl-CoA desaturase 1 and inflammatory cytokines, Prostaglandins Leukot. Essent. Fat. Acids, 88, 347, 10.1016/j.plefa.2013.02.002 Wada, 2008, Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice, J. Hepatol., 49, 441, 10.1016/j.jhep.2008.04.026 Nanji, 1994, Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats, Alcohol. Clin. Exp. Res., 18, 1280, 10.1111/j.1530-0277.1994.tb00119.x Huang, 2015, Endogenously elevated n-3 polyunsaturated fatty acids alleviate acute ethanol-induced liver steatosis, Biofactors, 41, 453, 10.1002/biof.1246 Naveau, 2010, Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease, J. Hepatol., 52, 895, 10.1016/j.jhep.2010.01.029 Neuhofer, 2013, Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation, Diabetes, 62, 1945, 10.2337/db12-0828 Gotoh, 2007, The regulation of adipogenesis through GPR120, Biochem. Biophys. Res. Commun., 354, 591, 10.1016/j.bbrc.2007.01.028 Gether, 2000, Uncovering molecular mechanisms involved in activation of G protein-coupled receptors, Endocr. Rev., 21, 90, 10.1210/edrv.21.1.0390 Oh, 2010, GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects, Cell, 142, 687, 10.1016/j.cell.2010.07.041 Ichimura, 2012, Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human, Nature, 483, 350, 10.1038/nature10798 Kang, 2004, Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids, Nature, 427, 504, 10.1038/427504a Bertola, 2013, Mouse model of chronic and binge ethanol feeding (the NIAAA model), Nat. Protoc., 8, 627, 10.1038/nprot.2013.032 Zhang, 2014, Characterizing plasma phospholipid fatty acid profiles of polycystic ovary syndrome patients with and without insulin resistance using GC-MS and chemometrics approach, J. Pharm. Biomed. Anal., 95, 85, 10.1016/j.jpba.2014.02.014 Hara, 2013, Free fatty acid receptors and their role in regulation of energy metabolism, Rev. Physiol. Biochem. Pharmacol., 164, 77, 10.1007/112_2013_13 Witters, 2006, Chutes and ladders: the search for protein kinases that act on AMPK, Trends Biochem. Sci., 31, 13, 10.1016/j.tibs.2005.11.009 Fulham, 2016, Sexual dimorphism in alcohol induced adipose inflammation relates to liver injury, PLoS One, 11, 10.1371/journal.pone.0164225 Carmen, 2006, Signalling mechanisms regulating lipolysis, Cell. Signal., 18, 401, 10.1016/j.cellsig.2005.08.009 Galitzky, 1995, Differential activation of beta 1-, beta 2- and beta 3-adrenoceptors by catecholamines in white and brown adipocytes, Fundam. Clin. Pharmacol., 9, 324, 10.1111/j.1472-8206.1995.tb00506.x Van Liefde, 1992, Multiple beta adrenergic receptor subclasses mediate the l-isoproterenol-induced lipolytic response in rat adipocytes, J. Pharmacol. Exp. Ther., 262, 552 Kawakami, 1987, Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells, J. Biochem., 101, 331, 10.1093/oxfordjournals.jbchem.a121917 Hauner, 1995, Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture, Diabetologia, 38, 764, 10.1007/s001250050350 Yan, 2013, Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation, Immunity, 38, 1154, 10.1016/j.immuni.2013.05.015 Kuda, 2009, n-3 Fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet, Diabetologia, 52, 941, 10.1007/s00125-009-1305-z He, 2004, Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors, Nature, 429, 188, 10.1038/nature02488 Kim, 2015, Endogenous ligand for GPR120, docosahexaenoic acid, exerts benign metabolic effects on the skeletal muscles via AMP-activated protein kinase pathway, J. Biol. Chem., 290, 20438, 10.1074/jbc.M115.657379 Ciana, 2006, The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor, EMBO J., 25, 4615, 10.1038/sj.emboj.7601341 Oka, 2009, 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55, J. Biochem., 145, 13, 10.1093/jb/mvn136 O'Neill, 2013, Metabolism of inflammation limited by AMPK and pseudo-starvation, Nature, 493, 346, 10.1038/nature11862 Itariu, 2012, Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial, Am. J. Clin. Nutr., 96, 1137, 10.3945/ajcn.112.037432 Serhan, 2010, Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not, Am. J. Pathol., 177, 1576, 10.2353/ajpath.2010.100322 Serhan, 2005, Resolution of inflammation: the beginning programs the end, Nat. Immunol., 6, 1191, 10.1038/ni1276 Johanns, 2016, AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B, Nat. Commun., 7, 10856, 10.1038/ncomms10856